Related references
Note: Only part of the references are listed.Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison
Ruth Horn et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2023)
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
Gabriel Morin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2022)
Expanding global access to genetic therapies
Anne W. T. Muigai
NATURE BIOTECHNOLOGY (2022)
Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series
Anna Karastaneva et al.
FRONTIERS IN PEDIATRICS (2022)
Trametinib as a promising therapeutic option in alleviating vascular defects in an endothelial KRAS-induced mouse model
H-L Nguyen et al.
HUMAN MOLECULAR GENETICS (2022)
Clinical benefit of alpelisib in pediatric patients with PIK3CA-related overgrowth spectrum (PROS): An EPIK-P1 analysis
G. Canaud et al.
ANNALS OF ONCOLOGY (2022)
Valuing genetic and genomic testing in France: current challenges and latest evidence
Catherine Lejeune et al.
JOURNAL OF COMMUNITY GENETICS (2022)
Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations
Kaitlyn Zenner et al.
GENETICS IN MEDICINE (2021)
AAPOR Reporting Guidelines for Survey Studies
Susan C. Pitt et al.
JAMA SURGERY (2021)
Case report: five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome
Christopher A. Ours et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2021)
Genetic Basis and Therapies for Vascular Anomalies
Angela Queisser et al.
CIRCULATION RESEARCH (2021)
EPIK-P2: A prospective phase 2, double-blind, randomized, placebo-controlled study of alpelisib in pediatric and adult patients (Pts) with PIK3CA-related overgrowth spectrum (PROS).
Guillaume Canaud et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
New and Emerging Targeted Therapies for Vascular Malformations
An Van Damme et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Kaposiform lymphangiomatosis effectively treated withMEKinhibition
Jessica B. Foster et al.
EMBO MOLECULAR MEDICINE (2020)
Monitoring Arteriovenous Malformation Response to Genotype-Targeted Therapy
Emily A. Edwards et al.
PEDIATRICS (2020)
A Primer on a Comprehensive Genetic Approach to Vascular Anomalies
Alexandra J. Borst et al.
FRONTIERS IN PEDIATRICS (2020)
Severe Lymphatic Disorder Resolved With MEK Inhibition in a Patient With Noonan Syndrome and SOS1 Mutation
Yoav Dori et al.
PEDIATRICS (2020)
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
Victoria E. R. Parker et al.
GENETICS IN MEDICINE (2019)
Vascular Anomalies Diagnosis of Complicated Anomalies and New Medical Treatment Options
Denise M. Adams et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child
Ramrada Lekwuttikarn et al.
JAMA DERMATOLOGY (2019)
Practical Genetic and Biologic Therapeutic Considerations in Vascular Anomalies
Denise M. Adams
TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
Vascular anomaly cases for the pediatric hematologist oncologistsAn interdisciplinary review
Denise M. Adams et al.
PEDIATRIC BLOOD & CANCER (2018)
The Impact of an Electronic Expensive Test Notification
Jacquelyn D. Riley et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
Lara Al-Olabi et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics
Dawn H. Siegel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Vascular Anomalies: From a Clinicohistologic to a Genetic Framework
Arin K. Greene et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2018)
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot et al.
NATURE (2018)
Advances in the Medical Management of Vascular Anomalies
Kiersten W. Ricci
SEMINARS IN INTERVENTIONAL RADIOLOGY (2017)
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
Denise M. Adams et al.
PEDIATRICS (2016)